Jubilant Ingrevia Limited

NSE:JUBLINGREA.NS

712.05 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q2
Revenue 10,30010,243.410,744.49,604.510,11110,686.611,294.811,526.312,989.811,593.912,758.7212,830.112,170.711,384.86,789.69-6,789.711,384.8
Cost of Revenue 5,071.17,868.88,351.75,0865,052.75,502.26,478.86,098.97,146.26,091.88,989.097,344.97,222.35,794.300-5,794.3
Gross Profit 5,228.92,374.62,392.74,518.55,058.35,184.44,8165,427.45,843.65,502.13,769.635,485.24,948.45,590.56,789.69-6,789.717,179.1
Gross Profit Ratio 0.5080.2320.2230.470.50.4850.4260.4710.450.4750.2950.4280.4070.491111.509
Reseach & Development Expenses 00000000000000000
General & Administrative Expenses 0000001,526.95000837.1900063.78500
Selling & Marketing Expenses 00000060.350009.08000213.0500
SG&A 1,735.91,668.11,837.51,500.71,604.2934.41,587.31,3581,550.1821.5846.27883.1758.71,190.9276.83500
Other Expenses 4,379.295.79587.885.285907072.9100.879.9693.669.659.81,514.9272,242.85859.8
Operating Expenses 4,379.21,668.11,837.53,905.24,220.84,340.94,093.94,214.44,624.34,406.92,398.63,661.53,301.13,091.61,791.7622,242.858-3,213.2
Operating Income 849.7706.5555.2701.4923.9843.5812.21,282.91,291.81,095.21,371.031,823.71,647.31,917.2950.658-1,161.2582,618.6
Operating Income Ratio 0.0820.0690.0520.0730.0910.0790.0720.1110.0990.0940.1070.1420.1350.1680.140.1710.23
Total Other Income Expenses Net -47.5-47-41.2-150.6-125.2-30.4-57-66.9-5159.9-225.9245-2.2-48.5-176.73387.3-188.1
Income Before Tax 802.2659.5514550.8798.7813.1755.21,2161,240.81,155.11,145.111,868.71,645.12,430.5773.928-773.9582,430.5
Income Before Tax Ratio 0.0780.0640.0480.0570.0790.0760.0670.1050.0960.10.090.1460.1350.2130.1140.1140.213
Income Tax Expense 212.2172.9221165.2223.8237.2232.1300.7398361.3459.2578537.2747.9230.28230.3-747.9
Net Income 590487.4292.5385.6574.9575.9523.07915.3842.8793.8685.911,290.71,107.91,682.6543.648-543.6581,682.6
Net Income Ratio 0.0570.0480.0270.040.0570.0540.0460.0790.0650.0680.0540.1010.0910.1480.080.080.148
EPS 3.733.061.852.433.623.623.285.755.314.994.318.126.9710.583.42-3.4210.56
EPS Diluted 3.733.061.852.433.623.623.285.755.34.994.318.126.9710.583.42-3.4210.56
EBITDA 1,348.91,095.3912.41,043.81,2631,250.71,110.61,582.91,601.61,509.61,476.992,219.82,022.62,874.8843.748-700.6582,302.4
EBITDA Ratio 0.1310.1070.0850.1090.1250.1170.0980.1370.1230.130.1160.1730.1660.2530.1240.1030.202